Requests the Commissioner to take administrative action, specifically a determination whether the listed drug (Lunelle) that has been voluntarily withdrawn from sale was withdrawn for safety or effectiveness reasons
🏛 Food and Drug Administration (FDA)FDA-2024-P-2952
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.